ACTIVE

APOTHEEK GLORIEUX

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result362,6 k €-8,4 %over 1 year
Gross margin568,2 k €-4,1 %over 1 year
Equity470,1 k €+1,6 %over 1 year
Workforce2,6 ETP+8,3 %over 1 year

Identity

Source · BCE/KBO

APOTHEEK GLORIEUX is a Private limited company incorporated in 1980. Its registered office is in Zwevegem. It employs on average 2,6 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0420.109.869
Incorporation
03/01/1980
Legal form
Private limited company
Registered office
Otegemstraat(Z) 42
8550 Zwevegem · FlandreSee on map
Contributed capital
18 600,00 €
Latest accounts
31/12/2025
Average workforce
2,6 ETP
Joint committees (1)
  • 313
Contacts
3 public details availableLog in to view
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 21 filings

Trend over 20 financial years

20252024202320222021
Income statement
Gross margin568,2 k €592,7 k €555,6 k €571,7 k €547,9 k €
EBITDA392,1 k €445,6 k €375,6 k €396,9 k €390,1 k €
Operating result359,6 k €405,8 k €336,8 k €360,8 k €364,5 k €
Net result362,6 k €395,9 k €335,6 k €361,7 k €365,8 k €
Balance sheet
Equity470,1 k €462,6 k €456,6 k €456 k €454,3 k €
Total assets838,4 k €730,5 k €744,9 k €762,1 k €762,1 k €
Cash106,1 k €11,1 k €64 k €92,5 k €99 k €
Debts368,3 k €267,9 k €288,3 k €306,1 k €307,9 k €
Other
Workforce2,6 ETP2,4 ETP2,8 ETP2,9 ETP3,0 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 24 ended

Active mandates

GLOPHARMA

Director · 0819.017.223

Represented by Glorieux Ruben

Active

Ended mandates

GLOPHARMA

Managing director · since 02 janvier 2015 · 0819.017.223

Represented by Ruben Glorieux

Ended
Frank Coene

Chairman of the board of directors · since 02 janvier 2014 · until 10 mai 2015

Ended
Frank Coene

Chairman of the board of directors · since 02 janvier 2014

Ended
PHILLAUR

Managing director · since 02 janvier 2014 · until 31 décembre 2014 · 0431.573.289

Represented by Pol Windels

Ended

Other companies at this address

Otegemstraat(Z) 42 8550 Zwevegem
CompanyCBE no.
Christine Van Laer● Active
1033.867.372
GLOPHARMA● Active
0819.017.223

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date18/06/202618/07/202530/09/202426/06/202324/06/202225/06/2021
General meeting10/06/202603/05/202504/05/202406/05/202307/05/202203/05/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 21 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202510/06/202618/06/2026DutchPDF
Abridged model31/12/202403/05/202518/07/2025DutchPDF
Abridged modelCorrection31/12/202304/05/202430/09/2024DutchPDF
Abridged model31/12/202304/05/202422/08/2024DutchPDF
Abridged model31/12/202206/05/202326/06/2023DutchPDF
Abridged model31/12/202107/05/202224/06/2022DutchPDF
Abridged model31/12/202003/05/202125/06/2021DutchPDF
Abridged model31/12/201902/05/202029/06/2020DutchPDF
Abridged model31/12/201804/05/201924/06/2019DutchPDF
Abridged model31/12/201705/05/201828/06/2018DutchPDF
Abridged model31/12/201606/05/201728/07/2017DutchPDF
Abridged model31/12/201507/05/201610/06/2016DutchPDF
Abridged model31/12/201422/04/201530/07/2015DutchPDF
Abridged model31/12/201303/05/201428/08/2014DutchPDF
Abridged model31/12/201204/05/201330/05/2013DutchPDF
Abridged model31/12/201105/05/201204/06/2012DutchPDF
Abridged model31/12/201007/05/201126/05/2011DutchPDF
Abridged model31/12/200903/05/201007/05/2010DutchPDF
Abridged model31/12/200802/05/200928/05/2009DutchPDF
Abridged model31/12/200703/05/200816/05/2008DutchPDF
Abridged model31/12/200605/05/200721/05/2007DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 24 ended

Active mandates

GLOPHARMA

Director · 0819.017.223

Represented by Glorieux Ruben

Active

Ended mandates

GLOPHARMA

Managing director · since 02 janvier 2015 · 0819.017.223

Represented by Ruben Glorieux

Ended
Frank Coene

Chairman of the board of directors · since 02 janvier 2014 · until 10 mai 2015

Ended
Frank Coene

Chairman of the board of directors · since 02 janvier 2014

Ended
PHILLAUR

Managing director · since 02 janvier 2014 · until 31 décembre 2014 · 0431.573.289

Represented by Pol Windels

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates09/06/2023
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates09/06/2015
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates21/04/2015
    BENAMING - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - WIJZIGING RECHTSVORM
    PDF
  • Mandates09/04/2015
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates12/02/2015
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates04/02/2014
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates20/06/2011
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Capital / shares21/10/2005
    KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025362,6 k €↓
  2. 2024
    Annual accounts 2024395,9 k €↑
  3. 2023
    Annual accounts 2023335,6 k €↓
  4. 2022
    Annual accounts 2022361,7 k €↓
  5. 2021
    Annual accounts 2021365,8 k €↓
  6. 2020
    Annual accounts 2020401,4 k €↑
  7. 2019
    Annual accounts 2019229,2 k €↓
  8. 2018
    Annual accounts 2018296 k €↑
  9. 2017
    Annual accounts 2017254,7 k €↓
  10. 2016
    Annual accounts 2016285,5 k €↑
  11. 2015
    Annual accounts 2015229,3 k €↑
  12. 2014
    Annual accounts 2014185,8 k €↑
  13. 2014
    Name changeAPOTHEEK GLORIEUX
  14. 2013
    Annual accounts 201399,8 k €↑
  15. 2012
    Annual accounts 201248,7 k €↓
  16. 2011
    Annual accounts 2011272,2 k €↑
  17. 2010
    Annual accounts 2010-4,2 k €↓
  18. 2009
    Annual accounts 200924,8 k €↓
  19. 2008
    Annual accounts 200851,8 k €↓
  20. 2007
    Annual accounts 200757 k €↑
  21. 2006
    Annual accounts 200640,2 k €
  22. 2006
    Name changeAPOTHEEK WINDELS
  23. 03/01/1980
    IncorporationPrivate limited company